Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Nitrous Oxide as Treatment for Major Depression - a Pilot Study [Phase 2]
Pilot Phase 2 trial evaluating nitrous oxide as a treatment for major depression; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Ketamine in Adolescents With Treatment-Resistant Depression [Phase 2]
Phase 2 trial update on ketamine for adolescents with treatment-resistant major depressive disorder has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Ketamine as an Adjunctive Therapy for Major Depression [Phase 1]
Phase 1 trial update on ketamine as an adjunctive therapy for major depression; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Effects and Consequences for Mother and Child From Treatment for Depression [Phase 4]
Phase 4 clinical trial update examining effects and consequences of depression treatment on mother and child; study terminated.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Genomics Used to Improve DEpression Decisions [NA]
Completed clinical trial investigating genomics to aid depression treatment decisions; results posted in 2020.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder [Phase 3]
Phase 3 relapse-prevention study of levomilnacipran ER in adults with major depressive disorder completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Ketamine for Relapse Prevention in Recurrent Depressive Disorder [Phase 1]
Phase 1 clinical trial evaluating ketamine for relapse prevention in recurrent depressive disorder has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Comparative Effectiveness Clinical Trial of MST Compared to ECT in Major Depressive Disorder [Phase 2, Phase 3]
A comparative effectiveness trial comparing MST to ECT in major depressive disorder has completed phases 2 and 3.
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment [Phase 2]
Phase 2 trial evaluating S 47445 as an adjunctive treatment to current antidepressant therapy in adults with major depressive disorder; stud…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Comparison of Anyu Peibo With Placebo in Treatment of MDD [Phase 2]
Phase 2 trial comparing Anyu Peibo with placebo in Major Depressive Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-27Clinical Trial Update: A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02) [Phase 3]
Phase 3 clinical trial evaluating rapastinel as adjunctive therapy in major depressive disorder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients. [NA]
Clinical trial investigating cranial electrical stimulation to modify suicide risk factors in psychiatric inpatients was terminated with res…
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder [Phase 3]
Phase 3 trial update assessing safety and efficacy of vilazodone in adolescents with major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: Accurate Clinical Study of Medication in Patients With Depression Via Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) of Venlafaxine [Phase 4]
Phase 4 clinical trial evaluating pharmacogenomics and therapeutic drug monitoring of venlafaxine in patients with depression.
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating ketamine as an alternative treatment to electroconvulsive therapy for major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Mood and Insulin Resistance in Adolescents At-Risk for Diabetes [Phase 2]
Phase 2 trial update investigating mood and insulin resistance in adolescents at risk for diabetes, completed.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder [Phase 2]
Phase 2 study evaluating TS-121 as adjunctive treatment for major depressive disorder was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Using the LENA System in Early Intervention - b [NA]
A completed clinical trial investigating the LENA System in early intervention for depression; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression [Phase 4]
Phase 4 trial looking at melancholic depression and insomnia as predictors of response to quetiapine in patients with major depressive disor…
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Efficacy of Repeated Ketamine Infusions for Treatment-resistant Depression [Phase 2]
Phase 2 trial of repeated ketamine infusions demonstrates efficacy in treatment-resistant depression. The results were posted on December 3,…
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Caregiver Burden and Distress in Hematopoeitic Stem Cell Transplant
A completed clinical trial studying caregiver burden and distress in hematopoietic stem cell transplant, focusing on depression, anxiety, fa…
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Integrating Mindfulness Into the Patient-Centered Medical Home (Phase 2) [NA]
Phase 2 trial update on integrating mindfulness into patient-centered medical home for depression and anxiety with completed status and resu…
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Comparison of the Efficacy, Safety, and Relapse of ECT to ECT Plus Agomelatine for Depressed Patients [Phase 4]
Phase 4 trial comparing electroconvulsive therapy (ECT) alone versus ECT plus agomelatine for major depressive disorder; study completed.
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: MBRP + Vortioxetine VS MBRP on Preventing Relapse in Chronic MA Users [Phase 4]
Phase 4 trial comparing MBRP plus vortioxetine versus MBRP alone for relapse prevention in chronic methamphetamine users.
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Open Label Extension for GLYX13-C-202, NCT01684163 [Phase 2]
Open-label extension of a Phase 2 study for GLYX13 in major depressive disorder has been terminated with results posted.